Mondaq UK: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Venner Shipley LLP
Many medical methods involve the use of a medical device or apparatus.
Venner Shipley LLP
The President of the European Patent Office has submitted questions to the Enlarged Board of Appeal which relate to the patentability of plants exclusively obtained by essentially biological processes and to T1063/18, ...
DLA Piper
We are pleased to present to you our periodical legal update on developments in the Russian pharmaceutical sector. It is intended to give you brief outline
HGF Ltd
HGF has been ranked in the 'Gold' and 'Silver' bands in The Financial Times special report ‘Europe's Leading Patent Law Firms' published on 9 July 2019.
McDermott Will & Emery
Investment in artificial intelligence (AI) and digital health technologies has increased exponentially over the last few years.
DLA Piper
Brexit is highly fluid; accordingly the legal situation and advice within this article is subject to change.
Arnold & Porter
He also highlights the increasingly challenging political and economic environment faced by industries.
HGF Ltd
In decision T1063/18, a EPO Technical Board of Appeal created controversy in ruling that the jurisprudence of the Enlarged Board of Appeal took precedence over Rule 28(2) of the EPC.
Reed Smith (Worldwide)
Germany is one of the most important patent litigation jurisdictions in Europe, making developments in its patent law very important to life sciences companies
Haseltine Lake Kempner LLP
On 1 February 2019 the UK IPO issued a notice that brings welcome news for biotech innovators wanting to use the services of the UK IPO.
Hogan Lovells
On May 16 the second edition of our new global series, Life Sciences and Health Care Horizons, took place in London featuring two panel discussions that focused on the challenges
DAC Beachcroft LLP
The plan to transform the NHS in England over the next decade will rely heavily on various technological developments that are now fit for the job, NHS Chief Information Officer Will Smart
Marks & Clerk
The application of electronics to the treatment of health conditions is nothing new. For years pacemakers have been used for the treatment of irregular heartbeats and other cardiovascular conditions.
Haseltine Lake Kempner LLP
Can a new referral to the Enlarged Board of Appeal finally settle whether plants and animals exclusively obtained by means of an essentially biological process are patentable at the EPO?
Haseltine Lake Kempner LLP
Abbott has commenced patent infringement proceedings, and applied for an interim injunction against Edwards.
Charles Russell Speechlys
Welcome to the June edition of our Pharmacy Brief
Kirkland & Ellis International LLP
Healthcare software as a service ("SaaS") platforms continue to be attractive targets for private equity sponsors and their portfolio companies.
Arnold & Porter
The Arnold & Porter Future Pharma Forum provides training and networking opportunities for junior and mid-level lawyers in the life sciences industry.
Arnold & Porter
Apologies that it has been a while since we've posted! We have lots in the pipeline, starting with this webinar.
Brahams Dutt Badrick French LLP
Acas has published new guidance on handling neurodiversity in the workplace. Neurodiversity refers to different ways the brain can use and interpret information. This includes attention deficit
Latest Video
Most Popular Recent Articles
Haseltine Lake Kempner LLP
On 1 February 2019 the UK IPO issued a notice that brings welcome news for biotech innovators wanting to use the services of the UK IPO.
DLA Piper
Brexit is highly fluid; accordingly the legal situation and advice within this article is subject to change.
McDermott Will & Emery
Investment in artificial intelligence (AI) and digital health technologies has increased exponentially over the last few years.
Abel & Imray
The UK's highest court has held that patents directed towards new medical uses for known products must disclose some sound scientific reasoning or directly relevant experimental evidence in suppor
Dehns
This article explores the implications of this aspect of the judgment and its potential impact on the value of second medical use patents.
DLA Piper
We are pleased to present to you our periodical legal update on developments in the Russian pharmaceutical sector. It is intended to give you brief outline
HGF Ltd
In decision T1063/18, a EPO Technical Board of Appeal created controversy in ruling that the jurisprudence of the Enlarged Board of Appeal took precedence over Rule 28(2) of the EPC.
Arnold & Porter
He also highlights the increasingly challenging political and economic environment faced by industries.
HGF Ltd
HGF has been ranked in the 'Gold' and 'Silver' bands in The Financial Times special report ‘Europe's Leading Patent Law Firms' published on 9 July 2019.
Venner Shipley LLP
The President of the European Patent Office has submitted questions to the Enlarged Board of Appeal which relate to the patentability of plants exclusively obtained by essentially biological processes and to T1063/18, ...
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with